Viral Infections Do Raise Blood Glucose Levels
Both viral and bacterial infections can cause hyperglycemia through multiple mechanisms including stress hormone release, inflammatory cytokine production, and direct effects on glucose metabolism—this is not limited to bacterial infections alone.
Mechanisms of Virus-Induced Hyperglycemia
Direct Viral Effects on Glucose Metabolism
Viral infections directly increase glucose production in hepatocytes. SARS-CoV-2 infects liver cells and stimulates gluconeogenesis through PEPCK (phosphoenolpyruvate carboxykinase) activation, leading to increased glucose production independent of pancreatic function 1.
Viruses reprogram cellular glucose metabolism to support their replication. Both oncogenic and non-oncogenic viruses enhance glycolysis in infected cells by interacting with glycolytic enzymes, increasing the catalytic activity of these enzymes to meet viral replication demands 2.
Viral infection of pancreatic β-cells can cause insulin deficiency. SARS-CoV-2 expresses ACE2 receptors on pancreatic β-cells, leading to direct β-cell damage, insulin deficiency, and frequent cases of severe diabetic ketoacidosis at hospital admission 3.
Inflammatory and Hormonal Mechanisms
Insulin resistance increases dramatically during viral infections. Blood glucose levels can increase approximately 2-fold during the inflammatory phase of viral infection, with the index of insulin resistance (glucose × insulin) elevated by 33% during acute infection and 28% during convalescence 4.
Serum insulin levels increase while glucagon decreases during viral infections. Despite elevated insulin levels, glucose intolerance persists due to marked insulin resistance, and restoration of insulin sensitivity takes longer than immediate recovery from the infection 4.
The severity of hyperglycemia during viral infection is independent of the infective agent. Studies comparing viral versus bacterial infections found that glucose intolerance occurs with both types of infections, with changes not dependent on whether the pathogen is viral or bacterial 4.
Clinical Evidence from Specific Viral Infections
COVID-19 (SARS-CoV-2)
COVID-19 infection is independently associated with hyperglycemia regardless of diabetic history. SARS-CoV-2 infection causes hyperglycemia even in non-diabetic patients with normal beta cell function, demonstrating direct metabolic effects beyond pre-existing diabetes 1.
Tremendous insulin requirements occur during severe COVID-19. The extent of insulin resistance in COVID-19 patients appears disproportionate compared with critical illness from other conditions, suggesting direct viral effects on glucose metabolism 3.
COVID-19 can trigger new-onset diabetes. Infection may induce new-onset diabetes through β-cell damage and insulin deficiency, with frequent severe DKA cases reported at hospital admission 3.
Other Viral Infections
Encephalomyocarditis virus causes hyperglycemia and abnormal glucose tolerance in experimental models. Multiple mouse strains developed hyperglycemia and abnormal glucose tolerance tests following viral infection, demonstrating virus-induced diabetes mellitus 5.
HSV infection causes significant changes in blood glucose levels during inflammatory phases. Blood glucose levels remained normal during early viral replication but increased approximately 2-fold during the inflammatory response phase 6.
Clinical Implications
Monitoring Requirements
All patients with viral infections, particularly COVID-19, require monitoring for new-onset diabetes. Patients without diabetes who contract viral infections need continuous glucose monitoring, as the virus can trigger new diabetes 3.
Blood glucose should be monitored every 2-4 hours during acute viral illness in diabetic patients. Regular self-monitoring or continuous glucose monitoring is essential, with careful adjustment of therapy to reach therapeutic goals 3.
Management Considerations
Acute hyperglycemia during viral infection upregulates ACE2 expression, potentially facilitating viral entry. This creates a vicious cycle where hyperglycemia promotes viral replication and inflammatory damage, worsening outcomes 3.
Chronic hyperglycemia downregulates ACE2 expression, making cells more vulnerable to inflammatory damage. This dual effect of hyperglycemia at different stages emphasizes the importance of glucose control throughout viral illness 3.
Key Clinical Pitfall
Do not assume hyperglycemia during infection is solely due to bacterial sepsis or stress response. Viral infections have distinct mechanisms for raising blood glucose, including direct hepatocyte infection with increased gluconeogenesis, pancreatic β-cell damage, and marked insulin resistance that exceeds what is typically seen with other critical illnesses 3, 1, 4.